Title : Position statement: topical calcineurin inhibitors in atopic dermatitis.

Pub. Date : 2018 Dec

PMID : 30288799






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSION: Topical calcineurin inhibitors are a suitable therapy for AD, and selection of the specific TCI should be based on factors which differentiate tacrolimus from pimecrolimus. Tacrolimus latexin Homo sapiens